Cargando...
Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits
Testosterone replacement therapy has been approved in the United States since the 1950s for men with “classical” hypogonadism. These men have specific and well-recognized hypothalamic, pituitary, or testicular conditions leading to deficient or absent endogenous testosterone. A more controversial tr...
Gardado en:
| Publicado en: | Androg Clin Res Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142681/ https://ncbi.nlm.nih.gov/pubmed/34041509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/andro.2020.0018 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|